189 related articles for article (PubMed ID: 25711724)
1. Downregulation of natriuretic peptide clearance receptor mRNA in vascular smooth muscle cells by angiotensin II.
Jiao Y; Yang Q
Fundam Clin Pharmacol; 2015 Jun; 29(3):260-8. PubMed ID: 25711724
[TBL] [Abstract][Full Text] [Related]
2. Increase of C-type natriuretic peptide expression by serum and platelet-derived growth factor-BB in human aortic smooth muscle cells is dependent on protein kinase C activation.
Mendonça MC; Doi SQ; Glerum S; Sellitti DF
Endocrinology; 2006 Sep; 147(9):4169-78. PubMed ID: 16777970
[TBL] [Abstract][Full Text] [Related]
3. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II modulates ANP-R2/ANP-C receptor-mediated inhibition of adenylyl cyclase in vascular smooth muscle cells: role of protein kinase C.
Palaparti A; Anand-Srivastava MB
J Mol Cell Cardiol; 1998 Aug; 30(8):1471-82. PubMed ID: 9737934
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II activates intermediate-conductance Ca2+ -activated K+ channels in arterial smooth muscle cells.
Hayabuchi Y; Nakaya Y; Yasui S; Mawatari K; Mori K; Suzuki M; Kagami S
J Mol Cell Cardiol; 2006 Dec; 41(6):972-9. PubMed ID: 16919291
[TBL] [Abstract][Full Text] [Related]
6. Role of calcium and protein kinase C in the activation of phospholipase D by angiotensin II in vascular smooth muscle cells.
Freeman EJ; Chisolm GM; Tallant EA
Arch Biochem Biophys; 1995 May; 319(1):84-92. PubMed ID: 7771808
[TBL] [Abstract][Full Text] [Related]
7. Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells.
Kai H; Fukui T; Lassègue B; Shah A; Minieri CA; Griendling KK
Mol Pharmacol; 1996 Jan; 49(1):96-104. PubMed ID: 8569718
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation.
Lassègue B; Alexander RW; Nickenig G; Clark M; Murphy TJ; Griendling KK
Mol Pharmacol; 1995 Oct; 48(4):601-9. PubMed ID: 7476884
[TBL] [Abstract][Full Text] [Related]
9. Novel role of protein kinase C-delta Tyr 311 phosphorylation in vascular smooth muscle cell hypertrophy by angiotensin II.
Nakashima H; Frank GD; Shirai H; Hinoki A; Higuchi S; Ohtsu H; Eguchi K; Sanjay A; Reyland ME; Dempsey PJ; Inagami T; Eguchi S
Hypertension; 2008 Feb; 51(2):232-8. PubMed ID: 18180404
[TBL] [Abstract][Full Text] [Related]
10. The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats.
Wu Y; Nakagawa S; Takahashi H; Kawabata Y; Suzuki E; Uehara Y
Hypertens Res; 2016 May; 39(5):295-301. PubMed ID: 26763849
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of smooth muscle 22α facilitates angiotensin II-induced ROS production via activation of the PKCδ-P47phox axis through release of PKCδ and actin dynamics and is associated with hypertrophy and hyperplasia of vascular smooth muscle cells in vitro and in vivo.
Lv P; Miao SB; Shu YN; Dong LH; Liu G; Xie XL; Gao M; Wang YC; Yin YJ; Wang XJ; Han M
Circ Res; 2012 Aug; 111(6):697-707. PubMed ID: 22798525
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-induced MAPK phosphorylation mediated by Ras and/or phospholipase C-dependent phosphorylations but not by protein kinase C phosphorylation in cultured rat vascular smooth muscle cells.
Cetin A; Ozturk OH; Tokay A; Akçit F; Cağlar S; Yeşilkaya A
Pharmacology; 2007; 79(1):27-33. PubMed ID: 17135774
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
Jaffe IZ; Mendelsohn ME
Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-dependent down-regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats.
Yoshimoto T; Naruse M; Naruse K; Shionoya K; Tanaka M; Tanabe A; Hagiwara H; Hirose S; Muraki T; Demura H
Endocrinology; 1996 Mar; 137(3):1102-7. PubMed ID: 8603580
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells.
Castejon AM; Zollner E; Tristano AG; Cubeddu LX
J Cardiovasc Pharmacol; 2007 Dec; 50(6):708-11. PubMed ID: 18091590
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
[TBL] [Abstract][Full Text] [Related]
17. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells.
Miyazaki R; Ichiki T; Hashimoto T; Inanaga K; Imayama I; Sadoshima J; Sunagawa K
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1263-9. PubMed ID: 18420994
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the insulin-like growth factor-I receptor gene: evidence for protein kinase C-dependent and -independent pathways.
Du J; Meng XP; Delafontaine P
Endocrinology; 1996 Apr; 137(4):1378-84. PubMed ID: 8625914
[TBL] [Abstract][Full Text] [Related]
19. Insulin-induced Akt activation is inhibited by angiotensin II in the vasculature through protein kinase C-alpha.
Motley ED; Eguchi K; Gardner C; Hicks AL; Reynolds CM; Frank GD; Mifune M; Ohba M; Eguchi S
Hypertension; 2003 Mar; 41(3 Pt 2):775-80. PubMed ID: 12623995
[TBL] [Abstract][Full Text] [Related]
20. Requirement of Ca(2+) and PKCdelta for Janus kinase 2 activation by angiotensin II: involvement of PYK2.
Frank GD; Saito S; Motley ED; Sasaki T; Ohba M; Kuroki T; Inagami T; Eguchi S
Mol Endocrinol; 2002 Feb; 16(2):367-77. PubMed ID: 11818507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
